A biotechnology company developing precision immunotherapies using proprietary T-cell receptor engineering platforms to target intracellular cancer antigens for solid tumor treatment.
A biotechnology company developing precision immunotherapies using proprietary T-cell receptor engineering platforms to target intracellular cancer antigens for solid tumor treatment.
